Schizophrenia Overview

Foundational guides to understanding schizophrenia, psychosis, and how the condition affects daily life.

Schizophrenia Overview Psychosis & Episodes Medications Side Effects Famous People with Schizophrenia Patient Experiences CBT for Psychosis Hospitalisation & Crisis Lifestyle & Wellbeing For Families & Caregivers Engineering Schizophrenia Research

Myth: Schizophrenia is a rare disease

Schizophrenia is often described as 'rare,' but the WHO estimates roughly 24 million people worldwide live with it — a public health issue of substantial scale.

Immigrants and schizophrenia: language, documentation, trauma

First-generation immigrants and their children carry an elevated risk of psychosis — and also a more complex path through any health system. Language, documentation, and trauma all shape what schizophrenia care looks like.

The WHO Comprehensive Mental Health Action Plan

The WHO Comprehensive Mental Health Action Plan 2013–2030 is the closest thing the world has to a global blueprint for community-based, rights-respecting mental health care. Here's what it says and where progress stands.

Getting a second opinion on a schizophrenia diagnosis

Schizophrenia is one of the highest-stakes diagnoses in medicine — and not always the right one. Here is when a second opinion is reasonable and how to actually get one.

Schizophrenia across cultures: different countries, different outcomes

Schizophrenia exists everywhere humans live, but its long-term course is not identical across cultures. The WHO international studies gave us some of psychiatry's most important — and contested — cross-cultural findings.

Schizoaffective vs schizophrenia vs bipolar

Three diagnoses, one diagnostic question: how do mood symptoms and psychotic symptoms relate to each other over time? The answer points to schizoaffective, schizophrenia, or bipolar.

Coordinated Specialty Care (CSC) for first-episode youth

Coordinated Specialty Care (CSC) is a team-based, evidence-supported model for first-episode psychosis. For young people, it dramatically improves outcomes.

fMRI research in schizophrenia

Functional MRI lets researchers watch the brain at work. In schizophrenia, two decades of fMRI studies have changed how we think about brain networks — but it is still not a diagnostic test.

Rural schizophrenia care: distance, telehealth, and gaps

Most US counties have no practising psychiatrist. For rural Americans with schizophrenia, the work of getting care is often the work of bridging miles, broadband gaps, and a workforce shortage that is decades deep.

The global burden of schizophrenia: prevalence and DALYs

Schizophrenia affects about 24 million people worldwide and contributes a disproportionate share of years lived with disability. Here's what the global numbers tell us — and what they don't.

The genetic risk of schizophrenia: what we know in 2026

Schizophrenia is highly heritable — but no single gene 'causes' it. A clear-eyed look at the genetic evidence as it stands in 2026, and what it does and doesn't mean for families.

The default mode network in schizophrenia

The default mode network is the brain's self-referential, mind-wandering circuit. In schizophrenia, it shows hyperconnectivity at rest and fails to deactivate during tasks, contributing to symptoms.

Brain imaging in schizophrenia: what MRI and PET show — and what they don't

MRI and PET scans show real differences between groups of people with and without schizophrenia, but they cannot diagnose any individual. Here is what imaging can and cannot do.

Schizophrenia vs dementia in older adults

Psychosis in an older adult can be late-onset schizophrenia, a dementia, delirium, or several other conditions. The differences guide treatment.

Schizophrenia symptoms in men: what's different

Schizophrenia in men typically begins in the late teens or early twenties, with more prominent negative symptoms and higher rates of substance use than in women. Treatment principles are similar, but presentation differs.

Brief psychotic disorder: a focused guide

Brief psychotic disorder is a short, often dramatic episode of psychosis that fully resolves within a month. It's distinct from schizophrenia and usually has a much better prognosis.

Brain volume changes in schizophrenia: what MRI studies show

MRI studies have shown small but consistent brain volume differences in schizophrenia. The findings are real — but interpreting them honestly is more nuanced than the headlines suggest.

Urban schizophrenia care: density, fragmentation, ED reliance

Cities have more psychiatrists per capita — and also more fragmented care, more emergency-department reliance, and worse outcomes for many of the most vulnerable patients. Density does not automatically equal access.

The striatum in schizophrenia

Decades of PET imaging have shown elevated presynaptic dopamine in the striatum of people with schizophrenia. The associative striatum, not the limbic striatum, is where the abnormality is largest.

Copy number variants (CNVs) in schizophrenia

Copy number variants are larger structural changes in DNA — duplications or deletions of whole gene-containing segments. A handful are now established as strong, rare risk factors for schizophrenia.

Gender disparities in schizophrenia: diagnosis and outcomes

Schizophrenia is not a one-shape illness. Onset, course, treatment response, and side-effect risk all differ between men and women — and ignoring these differences leaves both groups under-served.

Neuropsychological testing in schizophrenia

Neuropsychological testing measures the cognitive strengths and weaknesses of schizophrenia in detail — useful for treatment planning, school accommodations, and tracking change.

The prefrontal cortex in schizophrenia

The prefrontal cortex underlies the cognitive symptoms of schizophrenia. Reduced volume, lower activation during effortful tasks, and altered GABA interneuron function are among the most consistent findings.

22q11.2 deletion syndrome and schizophrenia

Roughly one in four people with 22q11.2 deletion syndrome develops schizophrenia or a related psychotic disorder. The condition is the strongest single genetic risk factor for schizophrenia known.

Religious minorities and schizophrenia care

Religious belief is woven through how many patients with schizophrenia experience and explain their illness. For minority faith communities, mainstream psychiatry often misses both the strength and the specificity.

Nursing home care for adults with schizophrenia

Long-term care for older adults with schizophrenia is one of the hardest navigation challenges in mental health. Here's what families and clinicians need to understand about the system.

The thalamus in schizophrenia

The thalamus relays nearly every sensory and cortical signal in the brain. In schizophrenia, parts of the thalamus shrink, its connections rewire, and signals between thalamus and cortex become less coordinated.

Polygenic risk scores for schizophrenia: what they can and can't tell you

Polygenic risk scores compress hundreds of small-effect schizophrenia variants into a single number. Useful in research, not yet ready for the clinic.

Schizophrenia vs DID: clearing up the confusion

The 'split mind' translation of schizophrenia has fuelled a century of confusion with dissociative identity disorder. Here is what actually separates the two conditions.

Schizophrenia vs psychopathy: not the same thing

Schizophrenia and psychopathy get blurred together in headlines and movies, but they are different conditions in different chapters of the diagnostic manual. Here is what each one actually is.